BD expands operations with US$4.3 million (€4 million) R&D Centre in Dublin and US$32 million (€30) million investment in Enniscorthy manufacturing plant in Ireland.
The new facility will be dedicated to advancing inaugural on-body injector device, the BD Evolve™ On-Body Injector, aligning with the growing demand for injectable drugs in the pharmaceutical pipeline.
The new 10,600 sq. ft. R&D facility in Blackrock, accommodating 35 high-tech employees, complements the existing Limerick R&D centre with over 300 personnel.
Additionally, it will function as the regional hub for sales, technical service, and corporate functional support teams.
Furthermore, it also expands its operations with a 40,000 sq. ft. facility to manufacture a new medical technology from the Peripheral Intervention business unit. These dual investments will result in the creation of more than 85 new employment opportunities.
Name Becton Dickinson
Type New Construction
Budget US$4.3 million (€4 million) R&D Centre & US$32 million (€30) million Manufacturing Plant